Neurocrine Biosciences shares owned by Acadian Asset Management
Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Acadian Asset Management
from 13F filings
Historical chart of Acadian Asset Management investment in Neurocrine Biosciences
Tip: Access up to 7 years of quarterly data
All positions including Neurocrine Biosciences held by Acadian Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neurocrine Biosciences by Acadian Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $46M | 351k | 131.69 |
| 2025-12-31 | $35M | 249k | 141.74 |
| 2025-09-30 | $5.5M | 40k | 140.18 |
| 2025-06-30 | $404k | 3.2k | 125.15 |
| 2025-03-31 | $337k | 3.1k | 110.35 |
| 2024-12-31 | $364k | 2.7k | 136.28 |
| 2024-09-30 | $2.2M | 19k | 115.00 |
| 2024-06-30 | $571k | 4.2k | 137.13 |
| 2024-03-31 | $478k | 3.5k | 137.91 |
| 2023-09-30 | $5.3M | 47k | 112.40 |
| 2023-06-30 | $2.3M | 24k | 94.09 |
| 2023-03-31 | $11M | 108k | 101.11 |
| 2022-12-31 | $6.4M | 53k | 119.22 |
| 2022-09-30 | $3.5M | 33k | 106.12 |
| 2022-03-31 | $27k | 293 | 92.15 |
| 2021-06-30 | $151k | 1.5k | 97.61 |
| 2021-03-31 | $447k | 4.6k | 97.22 |
| 2020-12-31 | $94k | 980 | 95.92 |
| 2020-09-30 | $1.1M | 11k | 96.17 |
| 2020-06-30 | $964k | 7.9k | 121.79 |
| 2020-03-31 | $98k | 1.1k | 86.88 |
| 2019-12-31 | $48k | 445 | 107.87 |
| 2019-03-31 | $8.0k | 91 | 87.91 |
| 2018-12-31 | $32k | 461 | 69.41 |
| 2017-12-31 | $8.0k | 99 | 80.81 |
| 2015-06-30 | $8.0k | 177 | 45.20 |